People Wouter Verdurmen Engineered proteins for drug delivery

Engineered proteins for drug delivery

Wouter Verdurmen’s research group focuses on designing and investigating engineered proteins that overcome delivery barriers, employing synthetic binding proteins for target recognition. Various (super-resolution) microscopy techniques as well as microfluidic tumor-on-a-chip approaches are used.

read more

Engineered proteins for drug delivery

Wouter Verdurmen’s research group focuses on designing and investigating engineered proteins that overcome delivery barriers, employing synthetic binding proteins for target recognition. Various (super-resolution) microscopy techniques as well as microfluidic tumor-on-a-chip approaches are used.


Fig 1) Infection of EGFR receptor-retargeted adenoviruses (green) in a co-culture spheroid of tumor cells (cyan) and fibroblasts (red).


Fig 2) Delivery of DARPins (red) targeting the cancer-associated Her2 receptor into a spherical tumor mass of BT474 cells (cyan).

Research group leader

Wouter Verdurmen PhD

+31 (0)24 361 42 63
contact

Aims of this research group

This group follows three aims that center around engineered proteins in drug delivery: understanding and improving how therapeutic proteins reach the cytosol, establishing methods to investigate tumor-targeted drug delivery in 3D and improving tumor delivery of protein drugs in complex tissues.

read more

Aims of this research group

The research performed within my group follows three aims that center around the use of engineered proteins in drug delivery.

Understanding and improving how therapeutic proteins reach the cytosol

Currently, only a minority of intracellular targets can be therapeutically addressed. Most potential intracellular targets have thus remained undruggable. One possible approach is the cytosolic delivery of therapeutic proteins. We aim to understand cytosolic protein translocation and develop effective strategies for cytosolic delivery of therapeutic proteins, utilizing protein domains found in nature to enable membrane translocation.

Establishing methods to investigate tumor-targeted drug delivery in 3D

To investigate how therapeutic proteins reach cells within a tumor, we use microfluidic tumor-on-a-chip devices. These models enable a controlled study of factors involved in drug delivery and will ultimately lead to a better quantitative understanding of the transport processes that occur in and around tumor tissues.

Improving tumor delivery of protein drugs in complex tissues

Following the second aim, my group aims to implement strategies to improve tissue penetration of novel therapeutic agents, focusing either on tuning of drug properties or locally altering the tumor microenvironment.
 
 

Team

Related research groups


Research group Genetic therapy for inherited retinal disease

Rob Collin's research group aimes at the development of new preclinical therapeutic strategies for selected genetic subtypes of inherited retinal dystrophy, by applying different approaches and using various cellular and animal models.

read more

Radboudumc Technology Center Microscopy

The Microscopic Imaging Center offers access to both standard and innovative advanced microscopy infrastructure and applications including technical operator-assistance and in-depth microscopic imaging knowledge.

read more

Radboudumc Technology Center Imaging

The Imaging Technology Center provides cutting-edge technology and service for imaging-related preclinical and clinical research questions. This covers the spectrum from molecule to man to population.

read more

Radboudumc Technology Center Animal research facility

This technology center offers advice and support from planning up to and including the conduct of animal research on behalf of biomedical research and education.

read more

Radboud Institute for Molecular Life Sciences

Our main aim is to achieve a greater understanding of the molecular mechanisms of disease. By integrating fundamental and clinical research, we obtain multifaceted knowledge of (patho)physiological processes. read more